VBIO Stock Catalyst: Valion Bio Appoints Dean Zikria as Interim CEO and Announces Board Leadership Transitions

Sep 23, 2026 · 1:16pm ET

The appointments were announced via an EDGAR filing.

Max move

+98.0%

High of day $4.85

Sparker timei

1:16pm ET

VBIO · Sep 23, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Valion Bio, Inc. (Nasdaq: VBIO) announced on September 23, 2026, the appointment of Dean Zikria as Interim CEO. The company also revealed changes in its board leadership, with Thomas Jensen stepping into a new role.

The appointments were detailed in an EDGAR filing under document number 0001683168-26-007300.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time VBIO sparks.

Download Sniper App →

Catch the next VBIO-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →